Strata Critical Medical Strikes Credit Agreement With JPMorgan Chase Bank National Association For Revolving Credit Loans In Total Amount Of Up To $30M

JPMorgan Chase & Co. -0.26%
Strata Critical Medical, Inc. Class A -0.72%

JPMorgan Chase & Co.

JPM

294.60

-0.26%

Strata Critical Medical, Inc. Class A

SRTA

4.15

-0.72%

Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), a leading provider of logistics and medical services in the organ transplant industry, today announced that the Company has entered into a credit agreement with JPMorgan Chase Bank, N.A. for secured, asset-based revolving credit loans in aggregate principal amount of up to $30.0 million, which, subject to certain conditions, may be increased up to an aggregate of $50.0 million (the "ABL Facility").

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.